This website uses cookies and, in some cases, third-party cookies, to improve user experience. By clicking the button or continuing to use the website you agree to the use of cookies. To find out more, including how to change your settings, see our Cookie Policy.

Teva Pharmaceutical 1.625% 2028-10 EUR

New bond issue: Teva Pharmaceutical (NYSE:TEVA) issued new debt notes (XS1439749364) for 750M EUR as of July 25, 2016. Listed at EuroTLX as of February 7, 2018.

Teva Pharmaceutical Finance NV operates in the Netherlands as a finance subsidiary of Teva Pharmaceutical Industries Limited, an Israeli multinational pharmaceutical company.

IssuerTeva Pharmaceutical Finance
Stock (Group)NYSE:TEVA
Bond TypeCorporate
CategorySenior, Callable
Maturity DateOctober 15, 2028
Residual Duration6 years, 10 months, 7 days
CurrencyEUR (Euro)
Coupon TypeFixed Rate
Coupon (Yearly)1.625%
Coupon FrequencyAnnual
Minimum Lot100,000 EUR
Additional Lots1,000 EUR
Issue DateJuly 25, 2016
Issued Amount750,000,000 EUR
Issue Price98.898%
Maturity Price100.000%
Home ExchangeDublin
Other ExchangesFrankfurt, Berlin, Stuttgart, EuroTLX, BondVision
Issue DocumentationIssue Prospectus
SectorHealth Care
RegionEurope developed

Bonds, Corporate, Health Care, Pharmaceuticals, Europe developed, Netherlands, EUR, Fixed Rate, Income

Next Teva Pharmaceutical 1.125% 2024-10 EUR